Bibliography

SIGNIFICANT PUBLICATIONS

  • Jutkiewicz EM, Bergman J (2004). Effects of dopamine D1 ligands on eye blinking in monkeys: efficacy, antagonism, and D1/D2 interaction. J Pharmacol Exp Ther 311: 1-8.

  • Jutkiewicz EM, Walker NP, Folk JE, Rice KC, Woods JH, and Traynor JR (2005). Comparison of peptidic and nonpeptidic delta-opioid agonists on guanosine 5’-O-(3-[35S]thio)triphosphate ([35S]GTPS) binding in brain slices from Sprague-Dawley rats. J Pharmacol Exp Ther 312: 1314-1320.

  • Jutkiewicz EM, Wood SK, Houshyar H, Hsin L-W, Rice KC, Woods JH (2005). The effects of CRF antagonists, antalarmin, CP154,526, LWH234, and R121919, in the forced swim test and on swim-induced increases in adrenocorticotropin in rats. Psychopharmacology 180: 215-223.

  • Jutkiewicz EM, Kaminsky S, Rice KC, Woods JH (2005). Differential behavioral tolerance to the -opioid agonist SNC80 ([(+)-4-[(R)--[(2S,5R)-2,5-dimethyl-4-(2-propenyl)-1-piperazinyl]-(3-methyoxyphenyl)methyl]-N,N-diethylbenzamide) in Sprague-Dawley rats. J Pharmacol Exp Ther 315: 414-422.

  • Jutkiewicz EM, Rice KC, Traynor JR, Woods JH (2005). Separation of the convulsions and antidepressant-like effects produced by the delta-opioid agonist SNC80 in rats. Psychopharmacology 182: 588-596.

  • Jutkiewicz EM, Torregrossa MM, Sobczyk-Kojiro K, Mosberg HI, Folk JE, Rice KC, Watson SJ, Woods JH (2006). Behavioral and neurobiological effects of the enkephalinase inhibitor RB101 relative to its antidepressant effects. Eur J Pharmacology 531: 151-159.

  • Jutkiewicz EM, Baladi MG, Rice KC, Woods JH (2006). The convulsive and electroencephalographic changes produced by nonpeptidic delta-opioid agonists in rats: comparison with pentylenetetrazol. J Pharmacol Exp Ther 317(3): 1337-1348.

  • Jutkiewicz EM, Baladi MG, Folk JE, Rice KC, Woods JH (2007). The delta-opioid receptor agonist SNC80 synergistically enhances the locomotor-activating effects of some psychomotor stimulants, but not direct dopamine agonists in rats. J Pharmacol Exp Ther 324(2):714-724.

  • Jutkiewicz EM (2007). RB101-mediated Protection of Endogenous Opioids: Potential Therapeutic Utility? CNS Drug Reviews. 13(2): 192-205. Review article.

  • Jutkiewicz EM, Nicolazzo DM, Kim MN, Gnegy ME (2008). Nicotine and amphetamine acutely cross-potentiate their behavioral and neurochemical responses in female Holtzman rats. Psychopharmacology 200(1): 93-103.

  • Jutkiewicz EM, Baladi MG, Cooper ZD, Narasimhan D, Sunahara RK, Woods JH (2009). A bacterial cocaine esterase protects against cocaine-induced epileptogenic activity and lethality. Ann Emerg Med 54(3):409-420.

RECENT PUBLICATIONS

  • Jutkiewicz EM, Brooks EA, Kynaston AD, Rice KC, Woods JH (2011). Patterns of nicotinic receptor antagonism: nicotine discrimination studies. J Pharmacol Exp Ther 339: 194-202.

  • Jutkiewicz EM, Roques BP (2012). Endogenous opioid as physiological antidepressant: complementary role of delta receptors and dopamine. Neuropsychopharmacology 37:303-304. Review article.

  • Jutkiewicz EM, Rice KC, Carroll FI, Woods JH (2013). Patterns of nicotinic receptor antagonism II: Cardiovascular effects in rats. Drug and Alcohol Dependence 131(3): 284-297